About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Amrutanjan Health Care Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Emcure Pharma
1519.85
105.05
7.43
33.69
45.11
202480
61.69
0.2
158.99
Torrent Pharma
4370.8
62.75
1.46
64.97
67.27
4311
42.34
0.73
224.32
Venus Remedies
755.25
51.45
7.31
52.85
14.29
4443
155.07
0
441.01
Fredun Pharma
1577.6
43.45
2.83
63.45
24.87
9021
132.17
0.04
299.47
Kwality Pharma
1492.95
42.2
2.91
54.5
27.39
23522
120.05
0
255.44
Onesource Specialty
1515
34.1
2.3
15.23
99.45
95694
1.54
0
516.29
JB Chem & Pharma
2069.9
18.7
0.91
45.3
45.69
1721
30.13
0.75
206.14
Sanofi Cons. Health
4430.5
18.65
0.42
104.25
42.5
1520
-9.24
1.69
118.26
Ipca Laboratories
1506.45
15.9
1.07
31.74
47.47
5447
13.43
0.27
271.64
Aurobindo Pharma
1247
15.4
1.25
36.69
33.99
45380
14.11
0
353.55
Panacea Biotec
334
13.75
4.29
-6.87
0
32726
-13.81
0
51.26
Anlon Healthcare
129.25
12.55
10.75
3.86
33.48
140321
0
20.18
Gland Pharma
1679.85
10.85
0.65
70.96
23.67
6247
1.48
1.07
592.08
FDC
372.1
10.25
2.83
13.95
26.68
5813
-3.39
1.34
140.48
Divi's Lab
6336.85
9.35
0.15
94.85
66.81
74025
14.97
0.47
562.08
Glaxosmithkline Phar
2521.7
8.95
0.36
58.85
42.85
6692
-5.3
2.14
115.94
Sun Pharma Inds.
1807.6
8.65
0.48
16.77
107.79
395093
12.19
0.89
101.45
Coral Laboratories
440.75
8.2
1.9
39.15
11.26
2948
-42.25
0.34
563.19
Fermenta Biotech
332.4
7
2.15
24.47
13.58
23496
27.53
0.75
130.16
SMS Pharmaceuticals
382.2
6.5
1.73
9.32
41
10865
97.37
0.1
74.13
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.